-
-
-
-
-
-
-
RXI Pharma (RXII) Reports Departure of Dr. Alexey Eliseev as Chief Business Officer
-
-
-
-
-
-
-
RXi Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
RXi Pharmaceuticals Reports Third Quarter 2016 Financial Results and Highlights Recent Corporate Developments
-
-
-
-
-
-
-
RXi Pharmaceuticals Provides Strategic Update
-
-
-
-
-
-
-
RXi Pharmaceuticals Receives Orphan Drug Designation for Samcyprone™ from the U.S. FDA for the Treatment of Malignant Melanoma Stage IIb to IV
-
-
-
-
-
-
-
RXI Pharma (RXII), Hapten Pharma Enter Exclusive License for Samcypron
-
-
-
924,292 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All